Organization type
- Academic research institution
Screening
-
Chemical libraries
- Natural product extracts: plants, microbial, animal (invertebrates, insects)
- Small molecules (including natural product, DNA encoded libraries and fragment libraries)
-
Fragment based screening
- Hit expansion. Medicinal chemistry programs.
- Virtual screening
Optimization phases
- Medicinal chemistry programs for hit to lead and lead optimization
-
Preclinical phase (including assay/model development and testing)(non-regulatory and regulatory)
- ADME / DMPK
- Safety
- Toxicology
Functional areas
- Artificial intelligence
- Bioinformatics
- Structural biology
Terapeutic areas
- Autoimmunity / Inflammation
- Blood and lymphatic system
- Cancer
- Cardiovascular
- Dermatology
- Infectious diseases
- Nervous Central System
- Ophthalmology / Optometry
- Rare diseases
Additional activities
- Government initiatives supporting drug and research collaborations
- Industry associations